Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02917213 : Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

1. First ST elevation AMI undergoing (or not) revascularization.

2. Sinus rhythm in the first 24 hours of the AMI.

3. Written informed consent. ( 4) Left ventricular ejection fraction < 45% measured by
echocardiography in the first 24-72 hours after AMI symptoms onset.

Exclusion Criteria:

1. Implantable defibrillation or stimulation devices not compatible with MRI.

2. Killip-IV class or other shock situations or marked peripheral hypoperfusion.

3. Aborted sudden death or other causes of possible acute brain damage attributed to
cerebral hypoperfusion.

4. Hemodynamically significant valvular disease or prosthetic heart valves.

5. Claustrophobia that impedes MRI scanning.

6. Atrial fibrillation (AF) in the first 24 hours after AMI.

7. Carotid Artery Disease diagnosed with stenosis greater than 50%.

8. Full oral anticoagulation prior to admission or indication of anticoagulation.

9. Defined pro-thrombotic conditions.

10. History of previous stroke in the last 6 months.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02917213      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740